IH vs. CHGG, LINC, NRDY, APEI, VTRU, VSTA, QSG, STG, YQ, and KUKE
Should you be buying iHuman stock or one of its competitors? The main competitors of iHuman include Chegg (CHGG), Lincoln Educational Services (LINC), Nerdy (NRDY), American Public Education (APEI), Vitru (VTRU), Vasta Platform (VSTA), QuantaSing Group (QSG), Sunlands Technology Group (STG), 17 Education & Technology Group (YQ), and Kuke Music (KUKE). These companies are all part of the "educational services" industry.
iHuman (NYSE:IH) and Chegg (NYSE:CHGG) are both small-cap consumer discretionary companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, community ranking, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.
Chegg received 794 more outperform votes than iHuman when rated by MarketBeat users. Likewise, 67.72% of users gave Chegg an outperform vote while only 50.00% of users gave iHuman an outperform vote.
In the previous week, Chegg had 1 more articles in the media than iHuman. MarketBeat recorded 1 mentions for Chegg and 0 mentions for iHuman. iHuman's average media sentiment score of 0.83 beat Chegg's score of -1.00 indicating that iHuman is being referred to more favorably in the media.
iHuman has higher earnings, but lower revenue than Chegg. Chegg is trading at a lower price-to-earnings ratio than iHuman, indicating that it is currently the more affordable of the two stocks.
iHuman has a beta of 0.35, indicating that its stock price is 65% less volatile than the S&P 500. Comparatively, Chegg has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500.
Chegg has a consensus target price of $7.31, indicating a potential upside of 101.72%. Given Chegg's higher possible upside, analysts plainly believe Chegg is more favorable than iHuman.
iHuman has a net margin of 17.78% compared to Chegg's net margin of 2.07%. iHuman's return on equity of 20.27% beat Chegg's return on equity.
4.9% of iHuman shares are held by institutional investors. Comparatively, 95.2% of Chegg shares are held by institutional investors. 63.6% of iHuman shares are held by insiders. Comparatively, 3.4% of Chegg shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
iHuman beats Chegg on 9 of the 16 factors compared between the two stocks.
Get iHuman News Delivered to You Automatically
Sign up to receive the latest news and ratings for IH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
